<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-KQF92WPT/bf118f08-804b-4e9d-87a8-dc0806103977/PDF"><dcterms:extent>608 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-KQF92WPT/6246a6eb-6420-40f7-916b-fdc923c9d6f4/TEXT"><dcterms:extent>67 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2013-2024"><edm:begin xml:lang="en">2013</edm:begin><edm:end xml:lang="en">2024</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-KQF92WPT"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-CFT6PFGK" /><dcterms:issued>2017</dcterms:issued><dc:creator>Triller Vrtovec, Katja</dc:creator><dc:format xml:lang="sl">številka:5/6</dc:format><dc:format xml:lang="sl">letnik:72</dc:format><dc:format xml:lang="sl">str. 357-381, 433-434</dc:format><dc:identifier>ISSN:0032-6976</dc:identifier><dc:identifier>COBISSID_HOST:15673937</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-KQF92WPT</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Zveza društev pravnikov Slovenije</dc:publisher><dcterms:isPartOf xml:lang="sl">Pravnik</dcterms:isPartOf><dc:subject xml:lang="en">Agency for Medicinal Products and Medicinal Devices of the Republic of Slovenia</dc:subject><dc:subject xml:lang="en">fees</dc:subject><dc:subject xml:lang="en">financing of public regulatory agencies</dc:subject><dc:subject xml:lang="sl">financiranje javnih agencij</dc:subject><dc:subject xml:lang="sl">Javna agencija za zdravila in medicinske pripomočke</dc:subject><dc:subject xml:lang="sl">načelo financiranja državnih nalog z obveznimi javnimi dajatvami</dc:subject><dc:subject xml:lang="sl">načelo uravnoteženega proračunskega financiranja javne porabe</dc:subject><dc:subject xml:lang="sl">načelo zakonitosti pri predpisovanju obveznih dajatev</dc:subject><dc:subject xml:lang="sl">namenske javne dajatve</dc:subject><dc:subject xml:lang="en">principle of balanced budgetary financing of public expenditures</dc:subject><dc:subject xml:lang="en">principle of financing state duties with taxes</dc:subject><dc:subject xml:lang="en">principle of legality in prescribing taxes</dc:subject><dc:subject xml:lang="sl">pristojbine</dc:subject><dc:subject xml:lang="sl">tarife</dc:subject><dc:subject xml:lang="en">tariffs</dc:subject><dc:subject xml:lang="en">taxes</dc:subject><dc:subject xml:lang="sl">upravne takse</dc:subject><dcterms:temporal rdf:resource="2013-2024" /><dc:title xml:lang="sl">Zakonska ureditev financiranja javnih regulatornih agencij v luči ustavnih izhodišč|</dc:title><dc:description xml:lang="sl">In the manuscript the author summarizes the constitutional principles of public financing and the regulatory framework for financing of public regulatory agencies. On a case study of financing the Agency for Medicinal Products and Medicinal Devices of the Republic of Slovenia (JAZMP) the author tries to establish whether or not the compliance with the constitutional principle of legality in prescribing taxes influences the efficiency and cost-effectiveness of public regulatory agencies performance. In the assessment she uses three criteria: first, does the law prescribe the criteria for setting the JAZMP fees, second, does the law prescribe the JAZMP services financed by fees, and third, does the law prescribe the supervision over JAZMP prescription of fees</dc:description><dc:description xml:lang="sl">Avtorica v prispevku povzema ustavna načela za urejanje financiranja nalog države in zakonsko ureditev financiranja javnih regulatornih agencij. Na primeru financiranja Javne agencije za zdravila in medicinske pripomočke kot največje regulatorne javne agencije v Sloveniji ugotavlja, ali spoštovanje načela zakonitosti pri predpisovanju javnih dajatev vpliva na učinkovitost in gospodarnost delovanja javnih regulatornih agencij. Pri tem uporabi tri merila: prvič, ali so merila za določitev višine namenskih javnih dajatev določena v zakonu; drugič, ali je obseg dejavnosti JAZMP, ki se financira z javnimi namenskimi dajatvami, določen v zakonu in tretjič, ali je nadzor nad določanjem javnih namenskih dajatev JAZMP določen v zakonu</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-KQF92WPT"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-KQF92WPT" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-KQF92WPT/bf118f08-804b-4e9d-87a8-dc0806103977/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Univerza v Ljubljani, Pravna fakulteta</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-KQF92WPT/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-KQF92WPT" /></ore:Aggregation></rdf:RDF>